- Home
- UTG vs PBH Comparison
UTG vs PBH Comparison
Compare UTG & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UTG
- PBH
- Stock Information
- Founded
- UTG 2003
- PBH 1996
- Country
- UTG United States
- PBH United States
- Employees
- UTG N/A
- PBH N/A
- Industry
- UTG Investment Managers
- PBH Biotechnology: Pharmaceutical Preparations
- Sector
- UTG Finance
- PBH Health Care
- Exchange
- UTG Nasdaq
- PBH Nasdaq
- Market Cap
- UTG 3.3B
- PBH 3.3B
- IPO Year
- UTG N/A
- PBH 2005
- Fundamental
- Price
- UTG $40.53
- PBH $62.98
- Analyst Decision
- UTG
- PBH Strong Buy
- Analyst Count
- UTG 0
- PBH 4
- Target Price
- UTG N/A
- PBH $98.50
- AVG Volume (30 Days)
- UTG 317.8K
- PBH 510.6K
- Earning Date
- UTG 01-01-0001
- PBH 11-06-2025
- Dividend Yield
- UTG 7.28%
- PBH N/A
- EPS Growth
- UTG N/A
- PBH 4.18
- EPS
- UTG 9.86
- PBH 4.26
- Revenue
- UTG $96,107,593.00
- PBH $1,120,150,000.00
- Revenue This Year
- UTG N/A
- PBH N/A
- Revenue Next Year
- UTG N/A
- PBH $2.33
- P/E Ratio
- UTG $3.20
- PBH $14.78
- Revenue Growth
- UTG 8.35
- PBH 0.63
- 52 Week Low
- UTG $25.26
- PBH $61.28
- 52 Week High
- UTG $35.29
- PBH $90.04
- Technical
- Relative Strength Index (RSI)
- UTG 76.55
- PBH 36.16
- Support Level
- UTG $38.16
- PBH $62.60
- Resistance Level
- UTG $38.91
- PBH $64.11
- Average True Range (ATR)
- UTG 0.45
- PBH 1.33
- MACD
- UTG 0.19
- PBH 0.18
- Stochastic Oscillator
- UTG 91.44
- PBH 20.83
About UTG Reaves Utility Income Fund of Beneficial Interest
Reaves Utility Income Fund is a closed-end management investment company. The company's investment objective is to provide a high level of after-tax income and total return consisting of tax-advantaged dividend income and capital appreciation. It invests a portion of its total assets in securities of utility companies, which may include companies in the electric, gas, water, telecommunications sectors, as well as other companies engaged in other infrastructure operations.
About PBH Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.